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Abstract
Pentachlorophenol (PCP) is an organochlorine pesticide that decreases the tumor-cell killing
(lytic) function of human natural killer (NK) cells. NK cells defend against tumor cells and virally
infected cells. They bind to these targets, utilizing a variety of cell surface proteins. This study
examined concentrations of PCP that decrease lytic function for alteration of NK binding to tumor
targets. Levels of PCP that caused loss of binding function were then examined for effects on
expression of cell-surface proteins needed for binding. Exposure to 10 μM PCP for 24 h (which
caused a greater than 70% loss of lytic function) decreased NK binding function (34.6%), and
CD11a (21.7%) and CD56 (26.2%) cell-surface proteins. Both binding function and cell-surface
proteins were decreased after longer exposures to lower concentrations of PCP. These data
indicate that continuous exposures to PCP decreased binding function as well as cell-surface
marker expression in NK cells and that these changes may in part explain the losses of lytic
function seen with these exposures. PCP exposures have been shown to increase the incidence of
blood and kidney cancers in humans. These data indicate that a possible explanation for this
increased risk may be loss of NK lytic function, which is at least in part due to the loss of the
ability of the NK cell to bind to tumor cells. These data also indicate that lost binding function
may be due to loss of important cell surface proteins.
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INTRODUCTION
NK cells prevent the development as well as the metastases of tumors (Lotzova, 1993;
Vivier et al., 2004). They also play a central role in defending against viral infections. Due
to these functions, they are the primary immune defense against tumor cells and virally
infected cells. Viral infection incidence has been shown to increase in individuals lacking
NK cells (Fleisher et al., 1982; Biron et al., 1989). Importantly, it has been shown that a
patient with a deficiency of NK cells suffered from both vulvar and cervical carcinomas
(Ballas et al., 1990). Additionally, a correlation between the size of the tumor and a decrease
in the number of NK cells was shown in breast cancer patients (Fulton et al., 1984). As these
cells are the front line of immune response against tumor and virally infected cells (due to
their ability to lyse target cells without prior sensitization), anything that interferes with their
function could lead to an increased incidence of tumors or viral infections. It has been
shown that exposure to the environmental contaminant dichlorodiphenyltrichloroethane
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(DDT) decreases both the number and cytotoxic function of human NK cells (Svensson et
al., 1994; Eskenazi et al., 2009). In keeping with its effect on NK cell numbers and function.
it has been found that DDT exposure at early ages (prior to age 14) causes and 5 fold
increase in the risk of breast cancer (Cohn et al. 2007).
The NK cell must physically bind to a target cell (be it a tumor cell or virally infected cell)
in order to destroy (lyse) the target. CD11a/CD18 form the functional LFA-1 adhesion
complex shown to be required for NK binding to tumor targets (Nitta et al., 1989). CD56, a
cognate of the neural cell adhesion molecule has also been shown to be important in NK
binding to targets (Nitta et al., 1989; Lotzova, 1993). CD2, an NK cell adhesion molecule,
has been implicated in activation of the cytotoxic signaling response (Lotzova, 1993). CD16
has a role as activating receptor of the NK lytic process with antibody-coated (Lotzova,
1993) and tumor targets (Mandelboim et al., 1999).
Pentachlorophenol (PCP) was at one time registered for use as an insecticide, fungicide,
herbicide, molluscicide, algicide, disinfectant, and ingredient in antifouling paints (Cirelli
1978). Its use was restricted in 1984 (EPA, 2001). It is now mainly used as a wood
preservative for power-line poles and fence posts. Approximately 80% of the PCP used in
the U.S. is for the treatment of wooden utility poles (ATSDR, 2001). As with other
organochlorine compounds PCP is quite stable. Due to its once widespread use and chemical
stability, it is a very significant environmental contaminant. Humans are exposed to PCP
through inhalation, absorption through the skin, and consumption of contaminated food and
water (ATSDR, 2001). Measurable levels of PCP have been detected in human blood and
urine (Atuma and Okor, 1985; CDC, 2005; Cline et al., 1989; Jones et al., 1986; Thornton et
al., 2002; Uhl et al. 1986). Levels ranging from 0.26 -5 μM were found in the serum of
individuals residing in PCP-treated log homes (Cline et al., 1989). Levels averaging about
0.15 μM were found in the serum of individuals with no known exposure (Cline et al., 1989;
Uhl et al., 1986). PCP is associated with cancers of the blood and kidney in humans (Demers
et al., 2006).
In previous studies we have shown that exposures to PCP decrease the lytic function of
human NK cells (Reed et al., 2004; Taylor et al., 2005; Nnodu and Whalen, 2008). Levels
ranging from 10 μM to 0.25 μM caused decreases in NK cell lytic function when cells were
exposed continuously for 24 h, 48 h, and 6 days (Reed et al., 2004; Nnodu and Whalen
2008). A 1 hour exposure to 10 μM PCP followed by 6 days in PCP-free media also resulted
in about an 80% decrease in the lytic function of NK cells (Taylor et al., 2005).
In the current study the effects of PCP exposures on the ability of NK cells to bind to target
cells was examined. As mentioned earlier, binding is an essential step in the process by
which NK cells lyse target cells. If PCP exposures were to decrease the ability of NK cells
to bind to targets, this could explain (at least in part) the PCP-induced loss of lytic function.
Certain cell surface proteins are needed for NK binding to target cells (Lotzova, 1993;
Mandelboim et al., 1999). Five cell surface proteins that are important in NK cells binding
to targets, CD2, CD11a, CD16, CD18, and CD56, were analyzed via flow cytometry to
determine whether PCP interferes with cell surface protein expression.. Effects of both
chronic and acute exposures to PCP were examined for their effects on binding and cell
surface protein expression.
MATERIALS AND METHODS
Isolation of NK cells
Peripheral blood from healthy adult (male and female) volunteer donors was used for this
study. Buffy coats (source leukocytes) obtained from Key Biologics, LLC (Memphis, TN)
Hurd et al. Page 2













were used to prepare NK cells. Highly purified NK cells were obtained using a rosetting
procedure. Buffy coats were mixed with 0.6-0.8 mL of RosetteSep human NK cell
enrichment antibody cocktail (StemCell Technologies, Vancouver, British Columbia,
Canada) per 45 mL of buffy coat. The mixture was incubated for 25 min at room
temperature (~ 25° C). Following the incubation, 7-8 mL of the mixture was layered onto 4
mL of Ficoll-Hypaque (1.077 g/mL) (MP Biomedicals, Irvine, CA) and centrifuged at 1200
g for 30-50 min. The cell layer was collected and washed twice with phosphate buffered
saline (PBS) pH 7.2 and stored in complete media (RPMI-1640 supplemented with 10%
heat-inactivated bovine calf serum (BCS), 2 mM L-glutamine and 50 U penicillin G with 50
μg streptomycin/ml) at 1 million cells/mL.
Chemical preparation
PCP was purchased from Fisher Scientific. PCP was dissolved in dimethylsulfoxide
(DMSO) (Sigma-Aldrich, St. Louis, MO) to give a 100 mM stock solution. Desired
concentrations of PCP were prepared by dilution of the stock into complete media. The final
concentration of DMSO for PCP exposures did not exceed 0.01%. Appropriate DMSO
controls were run.
Cell Treatments
NK cells (at a concentration of 1.5 million cells/ mL) were exposed to PCP or Control for 24
h, 48 h or 6 days. Following exposures, the cells were assayed for binding capacity or cell-
surface marker expression. Additionally, NK cells were exposed to PCP for 1 h; following
the 1 h exposure period, the PCP- containing or control media was removed and replaced
with fresh PCP-free media and the cells were incubated in compound-free media for 24 h,
48 h or 6 days prior being assayed for binding function or cell-surface protein expression.
The concentration range examined was 0.25- 10 μM PCP.
Cell Viability
Cell viability was determined by trypan blue exclusion to determine if the compound (at
varying concentrations and lengths of exposure) was cytotoxic to the NK cells. Cell numbers
and viability were assessed at the end of each exposure period. Viability was determined at
each concentration for each of the exposure periods. The viability of treated cells was
compared to that of control cells at each length of exposure (Whalen et al., 2003). Only
those concentrations where viability was unaffected were used at a given length of exposure.
Table 1 shows the viability of the cells after each length of exposure. It is important to note
that the concentrations of PCP used in the studies were not cytotoxic to the NK cells at any
of the lengths of exposure (compared to control NK cells), thus any changes in binding or
cell surface protein expression were not due to NK cell death.
Conjugation Assay
The percentage of target cells with bound NK cells was determined at two effector to target
ratios 12:1 and 6:1. The NK cells were treated as described above. Control and PCP exposed
NK cells were then suspended at a concentration of 240,000/50 μL (for the 12:1 ratio) and
120,000/50 μL (6:1 ratios). The target cell was the NK-susceptible K562 cell (human
chronic myelogenous leukemia). Target cells were suspended at a concentration of
20,000/50 μL. Tumor cells (50 μL) were then placed in the wells of microwell plates
containing 50 μL of control or PCP exposed lymphocytes. Each condition was tested in
triplicate. The plate was centrifuged at 300 g for 3 min and the cells were incubated at 37°
C, air/CO2, 19:1, for 10 min and then placed on ice. Following the incubation period, the
cells were gently resuspended with a micropipette, placed in a hemacytometer and viewed
under a light microscope. The number of target cells with two or more lymphocytes bound
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to their surface was counted as well as the total number of targets to determine the
percentage of tumor cells with lymphocytes bound. The minimum number of targets counted
per determination was 50-100 (Whalen et al., 1992).
Flow Cytometry
NK cells were exposed to the appropriate concentrations of PCP for the appropriate length
of time. Following exposure to PCP, the cells were washed and prepared for analysis on a
FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). The cells were washed
twice with ice-cold PBS and 100 μl of cell suspension (250,000-500,000 cells) was labeled
with 10 μl of one of the following antibodies: anti-CD2, CD11a, CD16 , CD18, and CD56
(Pharmingen, San Diego, CA). Anti-CD2, CD11a, CD16, and CD18 were FITC-conjugated
antibodies. Anti-CD56 was phycoerythrin (PE)-conjugated. Appropriate FITC- and PE-
conjugated isotype control antibodies were used. Each antibody was a monoclonal antibody
(mouse IgGκ) that was specific for the human cell surface protein, such as CD16. The
antibody-containing cell suspension was incubated for a minimum of 30 minutes on ice, in
the dark. Following the incubation period the cells were washed twice with ice-cold PBS (1
mL) and suspended in 500 μl of ice-cold 1% paraformaldehyde in PBS. Samples were
analyzed using the the FACSCalibur flow cytometer from Becton Dickinson
Immunocytometry Systems, Inc (BDIS), San Jose, CA. Instrument performance was
standardized weekly using Calibrite beads (BDIS) and the same instrument settings were
used for all acquisitions. The assays were sufficiently uniform to use the same forward
scatter (FSC), side scatter (SSC), and fluorescence (FL) settings. The sensitivity of the
instrument was constant. The acquisition and analysis software for flow cytometry data was
CELLQuest Pro from BDIS running on an Apple computer.
Statistical Analysis
Statistical analysis of the data was carried out utilizing ANOVA and Student's t test. Data
were initially compared within a given experimental setup by ANOVA. A significant
ANOVA was followed by pair wise analysis of control versus exposed data using Student's t
test, a p value of less than 0.05 was considered significant.
RESULTS
Effects of Exposures to PCP for 24 h, 48 h and 6 days on the Binding Function of NK Cells
NK cells were exposed to 2.5-10 μM PCP for 24 h, 2.5 and 5 μM PCP for 48 h, and 0.25-1
μM PCP for 6 days. Exposure to 10 μM PCP for 24 h caused a decrease in NK cell binding
function (34.6% ± 8.7%). 5 μM PCP for 24 h caused a 15.7% ± 10% decrease in binding
function while exposure to 2.5 μM PCP for 24 h caused no significant decrease (Figure 1) .
A 48 h exposure to 5 μM PCP caused a decrease of 20.8% ± 15% (Figure 1). When NK
cells were exposed to 1 μM PCP for 6 days, there was a significant decrease in tumor
binding function of 46.6% ± 21%. (Figure 1). To combine results from separate experiments
(using cells from different donors) the tumor binding caused by treated cells was normalized
to that of control cells in a given experiment.
Effects of Exposures to PCP for 1 h Followed by 24 h, 48 h, and 6 Days in PCP-Free Media
on the Binding Function of NK Cells
NK cells were exposed to PCP for 1 h after which the compound containing media was
removed and the cells were washed two times with compound-free media. The NK cells
were then suspended in PCP-free media for 24 h, 48 h or 6 days before assaying for tumor
binding function. The only condition that caused a significant decrease in binding function
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(26.0% ± 7.6%), was a 1 h exposure to 10 μM PCP followed by 6 days in PCP-free media
(Figure 2).
Effects of Exposures to PCP for 24 h, 48 h and 6 Days on Cell-Surface Protein Expression
Levels of key cell surface molecules involved in the NK cell interaction with target cells
were monitored using flow cytometry. Control and PCP-exposed cells were incubated with
fluorescent-labeled antibodies for specific cell surface markers. The antibodies used were
anti-CD2, CD11a, CD16, CD18, and CD56. A 24 h exposure to 5 μM PCP caused decreases
in CD11a of 22.9% ± 8.9% and in CD56 of 21.8% ± 10% (P< 0.05) When NK cells were
exposed to 10 μM PCP for 24 h, CD11a expression was decreased by21.7% ± 9.1% (P<
0.05) and CD56 expression was decreased by 26.2% ± 11.7% (P< 0.05) (as measured by
mean fluorescence intensity). Figures 3A and B shows the shift in peak fluorescence
intensity for a representative experiments of CD11a and CD56 at the 10 μM concentration.
When NK cells were exposed to 2.5 μM PCP for 48 h there were decreases in the expression
of CD16, CD18, and CD56 of 22.1% ± 16.7%, 15.9% ± 3.9%,and 28.7% ± 4.2%,
respectively (P<0.05). A 48 h exposure to 5 μM PCP also decreased expression of CD16,
CD18, and CD56. CD16 was decreased by 34.6% ± 16.6%, CD18 was decreased by 22.6%
± 5.7%, and CD56 was decreased by 37.7% ± 7.5% (P<0.05). Figures 4A-C show the shift
in fluorescence intensity for each of these proteins from a representative experiment at the 5
μM concentration. A 6 day exposure to 0.5 μM PCP caused a significant decrease only in
CD16 (21.2 ± 2.6%, P<0.05), while exposure to 1 μM PCP caused significant decreases in
each of the cell surface markers that were tested with the largest decrease being in CD16
(73.3% ± 8.8%, P<0.05). CD2, CD11a, CD18, and CD56 were decreased by 40.2% ±
13.4%, 47.8% ± 1.9%, 32.1% ± 7.4%, and 55.1% ± 23.5%, P<0.05. Figures 5 A-E show the
shift in fluorescence intensity for each of the proteins at the 1 μM PCP concentration from a
representative experiment.
Effects of Exposure to PCP for 1 h Followed by 24 h, 48 h, and 6 Days in PCP-Free Media
on Cell- Surface Protein Expression
A 1 h exposure to 10 μM PCP followed by 6 days in PCP-free media was the only condition
that caused any decrease in expression of any cell-surface protein. There was a slight
decrease in the expression of CD16 of 15.7% ± 5%. All the other lengths of incubation at
either 10 or 5 μM PCP caused no significant changes in any of the cell surface proteins
examined.
DISCUSSION
In past studies we found that the organochlorine pesticide PCP, caused very significant
decreases in the ability of human NK cells to destroy tumor target cells (Reed et al., 2004;
Taylor et al., 2005). Even a brief exposure to 10 μM PCP (1 h) could induce processes that
lead to dramatic decrease in lytic function in the 6 day period following the initial exposure
to PCP. As mentioned earlier, PCP is now mainly used as a wood preservative for power-
line poles and fence posts (ATSDR, 2001). However, due to past use in a wide variety of
applications, including the treatment of logs used in log homes, significant numbers of
people have been exposed to PCP. It has been found in the serum of humans living in PCP-
treated log homes at levels of 0.26 -5 μM Cline et al., 1989) and levels averaging about 0.15
μM were found in the serum of individuals with no known exposure (Cline et al.,1989; Uhl
et al., 1986). The levels of PCP found in human serum are in the range where we see effects
on NK lytic function (0.25 -10 μM) (Reed et al., 2004; Taylor et al., 2005). As we have
shown that PCP has negative effects on human NK immune function that can persist even
after its removal, it is important to address further the mechanism of PCP-induced loss of
NK lytic function. The purpose of the current study was to examine the effects of PCP on
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the ability of NK cells to bind to their targets and to determine if there was a decrease in cell
surface protein expression, that accompanied any loss of binding function. As NK cell
binding to targets is the first step of achieving target lysis any interference with binding
could, at least in part, explain the loss of lytic function seen with PCP exposures. Specific
cell surface proteins are used by NK cells to recognize and bind to their targets, thus any
decrease in binding could be explained by an accompanying decrease in specific cell surface
protein expression, which was also examined.
The results of the current study indicate that the loss of NK lytic function that was seen in
previous studies (Reed et al., 2004; Taylor et al., 2005) cannot be fully explained by loss of
binding function. For instance a 24 h exposure to 2.5 μM PCP caused 48% decrease in lytic
function but caused no loss of binding function (Figure 6A). Figure 6 plots the loss of lytic
function seen in a previous study (Reed et al., 2004) with the loss of binding function seen in
this study for ease of comparison. A 48 h exposure to 2.5 μM PCP caused a decrease in lytic
function and 70% but no decrease in binding function (Figure 6B). After a 6 day exposure to
0.25 μM PCP the loss of lytic function was 73% but there was no decrease in binding
function (Figure 6C). However, a 24 hour exposure to 10 μM PCP caused a decrease in lytic
function of 76% and a decrease in binding function of 35%. Thus, it appears that the lack of
ability of NK cells to bind to their target may be a contributing factor to the loss of lytic
function seen at some lengths and concentrations of PCP exposure. However, loss of binding
function does not explain the extent of loss of lytic function that has been seen with 24 h and
48 h continuous exposures to PCP. This same pattern has been seen with other compounds
that are able to block the lytic function of human NK cells. These include the organtoins,
tributyltin (TBT) and dibutyltin (DBT) (Whalen et al., 2002; Odman-Ghazi et al., 2003), the
flame retardants tetrabromobisphenol A (TBBPA) (Kibakaya et al., 2009) and
hexabromocyclododecane (HBCD) (Hinkson and Whalen, 2010) and the carbamate
pesticide ziram (Taylor and Whalen, 2009).
NK cells utilize specific cell surface proteins to recognize and bind to their targets. Thus,
any PCP exposures that caused loss of binding function were examined for their capacity to
alter expression of several cell surface proteins. CD11a, CD18, CD16, and CD56 have all
been shown to be important in binding to target cells (Lotzova, 1993: Mandelboim et al.,
1999). The results indicated that there was a very significant loss of the cell surface proteins
CD11a and CD56 in NK cells exposed to 10 μM PCP for 24 h. Exposure to 5 μM PCP for
24 h also caused a significant decrease in both CD2 and CD56. These exposures also caused
significant decreases in binding function as seen in Figure 1. A 48 h exposure to 5 μM PCP
caused decreases in CD16, CD18, and CD56 it also caused decreases in binding of about
21% (Figure 1). Finally, a 6 day exposure to 1 μM PCP caused the greatest decrease in
binding (47%) (Figure 1) and also caused the greatest percentage decreases in all of the five
cell surface proteins. Thus, there appears to be a significant association between loss of
binding function and a decrease in one or more of the cell surface proteins needed for
binding and lysis of tumor targets.
Studies examining the relationship between loss of NK binding function accompanying loss
of cell-surface proteins have been carried out with other environmental contaminants,
including butyltins, brominated flame retardants, and the carbamate pesticide (Whalen et al.,
2002a,b; Odman-Ghazi et al., 2003; Taylor et al., 2009; Kibakaya et al., 2009; Hinkson an
Whalen 2010; Hurd and Whalen, 2011). These studies, like the current study, have shown
that there is an association of loss of binding function and a decrease of one or more cell-
surface protein. The effects of TBT, DBT, TBBPA, HBCD, and ziram on the expression of
cell surface proteins have also shown that there were very significant decreases in CD16 in
NK cells under conditions where binding was decreased (Whalen et al., 2002; Odman-Ghazi
et al., 2003; Kibakaya et al., 2009; Hurd and Whalen, 2011; Hinkson and Whalen, 2010;
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Taylor et al., 2009). This is similar to what was seen with PCP exposures although PCP
caused decreases in all of the cell surface markers at 6 days which was not seen with any of
the other compounds tested.
Finally, the fact that PCP is found in human serum at levels that exceed those where NK
lytic function (Reed et al., 2004; Taylor et al., 2005; Nnodu and Whalen, 2008), binding
function, and cell surface protein levels are impaired, indicates that PCP may have the
capacity to increase the potential for tumor development in humans. It has already been
shown that individuals exposed to PCP have higher incidences of cancers (especially of the
blood) (Demers et al., 2006) and this may be due to the inability of their NK cells to prevent
tumor development due to PCP-induced decreases in NK function. Additionally, as
mentioned in the introduction other contaminants such as DDT that are also capable of
interfering with human NK function have been shown to increase the incidence of cancers in
exposed individuals (Svensson et al., 1994; Eskenazi et al., 2009; Cohn et al. 2007).
In summary the current study shows: 1.) Exposure of NK cells to PCP interferes with ability
of NK cells to bind to tumor target cells; 2.) PCP-induced loss of binding function does not
appear to explain the extent of the loss of NK cell ability to lyse tumor cells under some
conditions; 3.) PCP-induced loss of binding function can be accompanied by a significant
decrease in the NK cell surface protein, which have roles in NK binding to certain target
cells.
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Effects of 24 h, 48 h and 6 day continuous exposures to PCP on the ability of NK cells to
bind K562 tumor cells. Very light gray bars = NK cells exposed to 0.25 μM PCP; light gray
bars = NK cells exposed to 0.5 μM PCP; medium gray bars = NK cells exposed to 1 μM
PCP; Dark gray bars = NK cells exposed to 2.5 μM PCP; Very dark gray bar = NK cells
exposed to 5 μM PCP; Black bars = NK cells exposed to 10 μM PCP. Results are mean
±S.D. (n=12 for 24 h, 48 h and 6day exposures). * indicates that the decrease in binding was
statistically significant (p<0.01).
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Effects of 1 h exposures to PCP followed by 24 h, 48 h and 6 day in PCP-free media on the
ability of NK cells to bind to K562 tumor cells. Dark gray bar = NK cells exposed to 2.5 μM
PCP; Black bars = NK cells exposed to 5 μM PCP. Results are mean±S.D. (n=9 for all
lengths of exposure). * indicates that the decrease in binding was statistically significant
(p<0.01).
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Histograms from representative experiments showing effects of 24 h exposures to 10 μM
PCP on CD11a and CD56 expression in NK cells. A.) 24 h exposure to 10 μM PCP: Dashed
line = IgG control; thin solid line = control NK cells stained with anti-CD11a antibody; bold
line = PCP-exposed cells stained with anti-CD11a antibody; y axis = cell number; x axis =
fluorescence intensity . B.) 24 h exposure to 10 μM PCP: Dashed line = IgG control; thin
solid line = control NK cells stained with anti-CD56 antibody; bold line = PCP-exposed
cells stained with anti-CD56 antibody; y axis = cell number; x axis = fluorescence intensity.
Hurd et al. Page 12













Hurd et al. Page 13














Histogram from a representative experiment showing effects of 48 h exposures to 5 μM PCP
on CD16, CD18, and CD56 expression in NK cells. A.) 48 h exposure to 5 μM PCP:
Dashed line = IgG control; thin solid line = control NK cells stained with anti-CD16
antibody; bold line = PCP-exposed cells stained with anti-CD16 antibody; y axis = cell
number; x axis = fluorescence intensity . B.) 48 h exposure to 5 μM PCP: Dashed line = IgG
control; thin solid line = control NK cells stained with anti-CD18 antibody; bold line = PCP-
exposed cells stained with anti-CD18 antibody. C.) 48 h exposure to 5 μM PCP: Dashed line
= IgG control; thin solid line = control NK cells stained with anti-CD56 antibody; bold line
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= PCP-exposed cells stained with anti-CD56 antibody. ; y axis = cell number; x axis =
fluorescence intensity.
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Histogram from a representative experiment showing effects of 6 day exposures to 1 μM
PCP on CD2, CD11a, CD16, CD18, and CD56 expression in NK cells. A.) 6 day exposure
to 1 μM PCP: Dashed line = IgG control; thin solid line = control NK cells stained with
anti-CD2 antibody; bold line = PCP-exposed cells stained with anti-CD2 antibody; y axis =
cell number; x axis = fluorescence intensity. B.) 6 day exposure to 1 μM PCP: Dashed line =
IgG control; thin solid line = control NK cells stained with anti-CD11a antibody; bold line =
PCP-exposed cells stained with anti-CD11a antibody; y axis = cell number; x axis =
fluorescence intensity. C.) 6 day exposure to 1 μM PCP: Dashed line = IgG control; thin
solid line = control NK cells stained with anti-CD16 antibody; bold line = PCP-exposed
cells stained with anti-CD16 antibody; y axis = cell number; x axis = fluorescence intensity.
D.) 6 day exposure to 1 μM PCP: Dashed line = IgG control; thin solid line = control NK
cells stained with anti-CD18 antibody; bold line = PCP-exposed cells stained with anti-
CD18 antibody. E.) 48 h exposure to 1 μM PCP: Dashed line = IgG control; thin solid line =
control NK cells stained with anti-CD56 antibody; bold line = PCP-exposed cells stained
with anti-CD56 antibody. ; y axis = cell number; x axis = fluorescence intensity.
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Effects of PCP exposure on lytic function (◇) and binding function (■) (plotted on the
same graph). (A) 24 h exposure to PCP, (B) 48 h exposure to PCP, (C) 6 days exposure to
PCP.
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